Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Gastroenterology 140 , 903912 (2011)
10.1038/ncomms1722 Nat
What to Avoid
doi:10.1111/j.1464-410X.2012.11577.x
However, this approach has not been evaluated in clinical trials for safety and efficacy
Discontinuation and weight regain How often people stop the medication TRIUMPH-4 (n=445, 68 weeks, obesity with knee osteoarthritis): 18.2% on 12 mg, 12.2% on 9 mg, 4% on placebo 2 TRANSCEND-T2D-1 (n=537, 40 weeks, type 2 diabetes): 5.1% on 12 mg, 4.5% on 9 mg, 0% on placebo 3 Phase 2 (n=338, 48 weeks): 6 to 16% across doses, 1% on placebo 1 For comparison, Wegovys STEP-1 trial reported a discontinuation rate of around 7% due to side effects, and Mounjaros SURMOUNT-1 reported a similar rate
US$ 22.34
US$ 24.07
US$ 24.48
US$ 27.71
US$ 26.92
US$ 22.47
US$ 20.25
US$ 27.10
US$ 25.79
US$ 27.88
